Hospital Infection Therapeutics Market to Reach US$ 17.8 Bn by 2026

1. ©2019 Transparency Market Research, All Rights Reserved Hospital Infection Therapeutics Market Therapeutics - Anti-bacterial Drugs, Anti-fungal Drugs, Anti-viral Drugs; Infection - Hospital Acquired Pneumonia, Urinary Tract Infections, Gastrointestinal Disorders, Bloodstream Infections, Surgical Site Infections, Other Hospital Infections - Forecast 2018 - 2026 ©2019 Transparency Market Research, All Rights Reserved

2. ©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary: Global Hospital Infection Therapeutics Market Chapter 4 Market Overview Chapter 5 Market Outlook Chapter 6 Global Hospital Infection Therapeutics Market Analysis and Forecast, by Therapeutics Chapter 7 Global Hospital Infection Therapeutics Market Analysis and Forecasts, by Infection Chapter 8 Global Hospital Infection Therapeutics Market Analysis and Forecasts, by Region Chapter 9 North America Hospital Infection Therapeutics Market Analysis and Forecast Chapter 10 Europe Hospital Infection Therapeutics Market Analysis and Forecast Chapter 11 Asia Pacific Hospital Infection Therapeutics Market Analysis and Forecast Chapter 12 Latin America Hospital Infection Therapeutics Market Analysis and Forecast Chapter 13 Middle East & Africa Hospital Infection Therapeutics Market Analysis and Forecast Chapter 14 Competition Landscape

3. ©2019 Transparency Market Research, All Rights Reserved Hospital Infection Therapeutics Market: Snapshot This report studies the current as well as future prospects of the global hospital infection therapeutics market. • Increase in the geriatric population which is more prone to hospital-acquired infections, significant patient population in developing countries demanding proper treatment, and investments by public and private players for R&D on anti-infective drugs against resistant bacteria are the major factors driving the global hospital infection therapeutics market. • • Major players operating in the global hospital infection therapeutics market are Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline plc, AstraZeneca, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Allergan plc. ©2019 Transparency Market Research, All Rights Reserved

4. ©2019 Transparency Market Research, All Rights Reserved ©2019 Transparency Market Research, All Rights Reserved

5. ©2019 Transparency Market Research, All Rights Reserved Reports Highlights • global hospital infection therapeutics market was valued at US$ 14.4 Bn in 2017 and is projected to expand at a significant CAGR of 2.4% from 2018 to 2026. • Based on infection, the global hospital infection therapeutics market has been divided into hospital acquired pneumonia, surgical gastrointestinal disorders, urinary tract infections, and other hospital infections. site infections, bloodstream infections, Increase in R&D to Develop Novel Antibiotics to Boost Market • Hospital acquired as well as community-associated infections due to highly resistant microbes present a major threat to public health. • ©2019 Transparency Market Research, All Rights Reserved Request Sample

6. ©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U